AEGERA THERAPEUTICS Trademark

Trademark Overview


On Monday, June 12, 2000, a trademark application was filed for AEGERA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the AEGERA THERAPEUTICS trademark a serial number of 76067783. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Saturday, September 12, 2009. This trademark is owned by Exogen Neurosciences Inc.. The AEGERA THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical, medical and therapeutic products, namely small molecule pharmaceuticals, protein pharmaceuticals, antisense pharmaceuticals, cell therapy products, namely skin derived stem cells, for implantation into human tissues and organs, for use in the treatment of tumor shrinkage and death, cellular survival, apoptosis, regeneration and growth in the area of oncology, neurology, apoptosis, pain relief, tissue and organ regeneration and gene therapy

Product research and development, namely, development and expression of adenovirus vectors, screening for small molecules, determining role of genes with suspected neuronal involvement, chemistry optimization, determining routes to differentiate stem cells, in the fields of oncology, neurology, apoptosis, pain relief, tissue and organ regeneration and gene therapy
aegera therapeutics

General Information


Serial Number76067783
Word MarkAEGERA THERAPEUTICS
Filing DateMonday, June 12, 2000
Status710 - CANCELLED - SECTION 8
Status DateSaturday, September 12, 2009
Registration Number2682250
Registration DateTuesday, February 4, 2003
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 12, 2002

Trademark Statements


Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and ServicesPharmaceutical, medical and therapeutic products, namely small molecule pharmaceuticals, protein pharmaceuticals, antisense pharmaceuticals, cell therapy products, namely skin derived stem cells, for implantation into human tissues and organs, for use in the treatment of tumor shrinkage and death, cellular survival, apoptosis, regeneration and growth in the area of oncology, neurology, apoptosis, pain relief, tissue and organ regeneration and gene therapy
Goods and ServicesProduct research and development, namely, development and expression of adenovirus vectors, screening for small molecules, determining role of genes with suspected neuronal involvement, chemistry optimization, determining routes to differentiate stem cells, in the fields of oncology, neurology, apoptosis, pain relief, tissue and organ regeneration and gene therapy

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateSaturday, September 12, 2009
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateSaturday, September 12, 2009
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAEGERA THERAPEUTICS INC.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressQUEBEC H3E 1A8
CA

Party NameAEGERA THERAPEUTICS INC.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressQUEBEC H3E 1A8
CA

Party NameAEGERA THERAPEUTICS INC.
Party Type11 - New Owner Before Publication
Legal Entity Type99 - Other
AddressQUEBEC H3E 1A8
CA

Party NameExogen Neurosciences Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMontreal, PQ H2W 2P2
CA

Trademark Events


Event DateEvent Description
Saturday, September 12, 2009CANCELLED SEC. 8 (6-YR)
Friday, January 4, 2008CASE FILE IN TICRS
Tuesday, February 4, 2003REGISTERED-PRINCIPAL REGISTER
Tuesday, November 12, 2002PUBLISHED FOR OPPOSITION
Wednesday, October 23, 2002NOTICE OF PUBLICATION
Friday, August 16, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 5, 2002Sec. 1(B) CLAIM DELETED
Friday, July 5, 2002CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 29, 2002NON-FINAL ACTION MAILED
Friday, July 5, 2002PAPER RECEIVED
Tuesday, October 23, 2001LETTER OF SUSPENSION MAILED
Monday, September 17, 2001PREVIOUS ALLOWANCE COUNT WITHDRAWN
Monday, June 4, 2001APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 14, 2001CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 8, 2000NON-FINAL ACTION MAILED
Friday, November 3, 2000ASSIGNED TO EXAMINER